ABT vs PFE

Abbott Laboratories against Pfizer — live side-by-side technical comparison.

Prices as of 2026-10-16T20:03:40+00:00 UTC · updates daily

Who leads right now

PFE leads 3 of the 5 windows we measure — over 1 month ABT is +2.5% and PFE +7.7%; over year to date ABT is -16.3% and PFE +18.8%. The ABT/PFE price ratio stands at 3.546, below its 50-day average of 3.7885, and below the 200-day average of 3.8744. A ratio above its own average means ABT is gaining on PFE; on this reading the recent edge belongs to PFE.

Performance side by side

ABTPFE
Price$104.89 $29.58
1 day +0.2% +0.5%lead
5 days +5.3%lead +4.6%
1 month +2.5% +7.7%lead
6 months +9.9%lead +8.7%
Year to date -16.3% +18.8%lead
52-week position 46% of range 95% of range
52-week range $81.97–$132.03 $23.62–$29.88
vs 50-day average below $105.87 above $27.97
vs 200-day average above $102.81 above $26.56
RSI (14) 62 61
Next earnings 2026-10-212026-11-03

Where each one stands

ABT — Abbott Laboratories

ABT trades at $104.89, below its 50-day average of $105.87, and above the 200-day at $102.81. It sits at 46% of its 52-week range ($81.97–$132.03); 14-day RSI is 62, in neutral territory; an average session moves it about 2.3%. For levels, the first level overhead is $105.87 (0.9% away) and the first support below is $104.55 (0.3% down). On the checklist the page runs for every asset, 5 of 6 checks read bullish — the lean is bullish.

PFE — Pfizer

PFE trades at $29.58, above its 50-day average of $27.97, and above the 200-day at $26.56. It sits at 95% of its 52-week range ($23.62–$29.88); 14-day RSI is 61, in neutral territory; an average session moves it about 1.9%. For levels, the first level overhead is $30.00 (1.4% away) and the first support below is $28.85 (2.5% down). On the checklist the page runs for every asset, 6 of 6 checks read bullish — the lean is bullish.

Which one moves harder

ABT is the more volatile of the two — an average session moves it 2.3% against 1.9% for PFE, so an identical position size carries roughly 1.2× the daily risk.

What would change the picture

The comparison turns on those levels: ABT clearing $105.87 or losing $104.55; PFE clearing $30.00 or losing $28.85. Until one of them gives way, the relative reading above stands.

Questions people ask about ABT vs PFE

Which is performing better right now, ABT or PFE?
Over the past month ABT is +2.5% and PFE is +7.7%, so PFE is ahead on that window. Year to date the figures are -16.3% for ABT and +18.8% for PFE.
Is ABT or PFE more volatile?
ABT is the more volatile of the two — an average session moves it 2.3% against 1.9% for PFE, so an identical position size carries roughly 1.2× the daily risk.
What are the key levels for ABT and PFE?
ABT: resistance $105.87, support $104.55; PFE: resistance $30.00, support $28.85. Levels come from recent swing zones and round numbers, recomputed daily.
When do ABT and PFE report next?
ABT: 2026-10-21. PFE: 2026-11-03. Earnings reset both the trend and the levels above, so a comparison made today is only good until the next report.
What does the ABT/PFE ratio mean?
It is simply ABT's price divided by PFE's — 3.546 today. When the ratio rises, ABT is outperforming; when it falls, PFE is. Comparing it to its own 50- and 200-day averages shows whether the current leadership is new or long-standing.

Full technical briefs

ABT →
Abbott Laboratories
Full technical brief: trend, levels, chart, news
PFE →
Pfizer
Full technical brief: trend, levels, chart, news

Related comparisons

JNJ vs LLYABBV vs LLYLLY vs UNHLLY vs MRKLLY vs TMOAMGN vs LLYGILD vs LLYABT vs LLY